All at once, I'm free

Implanted at the time of cataract surgery or as a stand-alone procedure, iStent inject® can help reduce your eye pressure and, at the discretion of an eye doctor, may reduce your reliance on glaucoma medication.

Learn More About iStent inject®

Important Safety Information »

A Tiny Implant

A Huge Impact

iStent inject® is one of the smallest medical implants known to be implanted in the human body and can effectively lower IOP, one of the most important risk factors for glaucoma.

Glaukos started a revolution in glaucoma surgery and treatment with the development of the first Micro-Invasive Glaucoma Surgery device. To date, trabecular micro-bypass technologies such as iStent® and iStent inject®, have been implanted in over 400,000 eyes around the world, with more patients benefitting from these procedures every day.

See How iStent inject® Works

Important Safety Information »

See Glaucoma in a New Light

If you’ve been diagnosed with glaucoma, don’t get discouraged. Get informed. Learn about your condition and understand just how much you still have to look forward to.

Learn More

With new treatment options, the future is bright

As healthcare advances, you have access to more options to help treat and control your eye pressure associated with open-angle glaucoma. Learn about the range of options available – from using prescription eye drops to implanting the advanced iStent inject® during cataract surgery or as a stand-alone procedure – and decide which option may be best for you.

Start Today

Important Safety Information »

Find out more about iStent inject®

Help is right around the corner. Leading ophthalmologists in the United Kingdom offer iStent inject® as part of their treatment for glaucoma. You can enquire if you are a suitable candidate for iStent inject® by contacting an ophthalmologist near you.

Contact Us

Sign Up For News & Updates

Sign Up For Investor-Related Email Alerts

Follow Us

logo facebook logo linkedin logo instagram
Glaukos is excited to announce that we have acquired Avedro, Inc.!
Read more about the acquisition » To learn more about corneal health therapies that are now a part of Glaukos’ portfolio click here »